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Increasing life span and lack of medication for prevention or treatment of progressive dementias will significantly increase the
number of individuals with advanced dementia worldwide. Providing optimal care for them will stretch health care resources
and will require evaluation of different treatment strategies. This paper is presenting measures that may be used in this patient
population. Evaluation of global goals of palliative care may include measuring quality of life by QUALID scale, comfort by DSDAT scale, and engagement by MPES scale. Symptom control may be achieved by measuring pain by PAINAD or PACSLAC scales,
by evaluating behavioral symptoms and their management (agitation by SOAPD scale, apathy by AES scale and rejection of care
by RTC-DAT scale), and by monitoring patients for dyspnea using RDOS scale. Outcomes of palliative care at the end of life may
be evaluated by EOLD-CAD scale and by determining family satisfaction with care (EOLD-SWC). Items included in these scales,
psychometric properties, and research use of these scales are described. It is hoped that information in this paper will stimulate
research interest in this important area.

1. Background
The authors of this review both enjoy international collaboration and started working together almost 20 years ago when
they discovered that they have a common concern for persons
with advanced dementia. The collaboration started by sharing
scales that can be used for research in population. Initially,
U.S. discomfort and dementia staging scales were used in
Dutch studies that investigated treatment of pneumonia [1–
3]. The Dutch translation of these scales was evaluated and
additional work assessed a cut off for severe dementia [4] and
the staging of the items [5] and the Dutch investigators also
evaluated a new U.S. set of scales for dementia at the end of life
[6]. Recent work developed also from sharing newly collected
[3] and existing data [7]—the Dutch author analyzing the
U.S. data and vice versa. Where previous work focused on
pneumonia, newer work was on modifiable factors that are
increasing risk of behavioral symptoms of dementia [7]. The
common theme in this research was concern for quality of life

of person with advanced dementia that could be supported
by palliative care, as summarized in recent work defining
domains and recommendations for palliative in dementia [8].
The authors share a belief that barriers to performing
high-quality research in this population can be overcome, and
one important barrier was the lack of outcome measures with
optimal psychometric properties specific for this population.
The importance of measuring outcomes at the end of life
in persons with dementia is increased by three factors. The
first one is increasing longevity that exposes more people to
the risk of development of dementia. The second factor is
failure of several medications that were developed to stop
progression or cure Alzheimer’s disease, the most common
cause of dementia. Development of these drugs was based on
the amyloid hypothesis tested in a transgenic mouse model
and their failure may indicate that the hypothesis does not
apply in most persons with Alzheimer’s disease [9]. Therefore,
although other avenues are also being investigated, there is no
effective drug that would prevent or cure Alzheimer’s disease
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on the horizon and the number of persons who are dying with
dementia is going to increase significantly.
The third factor is recognition that current strategies
for treatment of persons with dementia at the end of life
may not be optimal. Some care providers may not consider
that most causes of dementia are progressive and ultimately
terminal diseases. However, there is also a need to treat
chronic diseases and intercurrent diseases (e.g., pneumonia)
that may cause discomfort and bothersome symptoms. A
need for improvement of care for persons with advanced
dementia is being recognized and an example of this effort is
the movement to change the culture of care for persons with
dementia and make it person centered which was recently
introduced [10]. All introduced changes should be carefully
investigated to assure that they actually improve care.
Measuring quality of care is difficult in persons with
advanced dementia who are nonverbal and cannot report
how they feel. Caregivers are limited to infer the condition of
persons with dementia from observation of their behaviors
and nonverbal communications. However, these observations may be quite important because they may uncover
physical or psychiatric conditions that require treatment
or unmet needs of the person with dementia. Although
experienced clinicians may be able to interpret their observations and implement proper measures, it may be helpful
if the observations are guided by a formal strategy. Formal
observations are, of course, necessary for conducting research
in persons with advanced dementia and may form a scale
that measures specific facet of dementia care. Several such
scales were developed and used in research and this paper will
describe some of them. We will discuss the background and
properties of selected measures which we feel conceptually
capture the most relevant outcomes in advanced dementia
and at the end of life.
We first provide measures for assessment of global goals
of palliative care in dementia; quality of life and absence of
discomfort [8]. We also discuss assessment of engagement
that is important for quality of life. The most important
symptoms at the end of life with dementia are pain, shortness
of breath, and behavioral symptoms [11, 12]. We discuss measures for each of these symptoms, and regarding behaviors,
we include social behaviors when discussing rejection of care
and engagement. We conclude with satisfaction with care in
the form of a family evaluation of care which is an important
outcome at the end of life on its own [13].

2.1. Quality of Life. A number of scales have been devised
to measure quality of life in persons with severe dementia,
but all except the QUALID [14] have a subjective component
and floor effects. The Quality of Life in Alzheimer’s Disease
Scale [15] has been found useful only for persons with MiniMental State Examination (MMSE; [16]) scores ≥ 3. The
Cornell-Brown Scale for Quality of Life in Dementia [17],
derived from the Cornell Scale for Depression in Dementia
[18] is limited by its requirement of a joint interview of
caregiver and patients and appears to be useful primarily with
subjects having an MMSE score > 8. Use of the Quality of
Life in Dementia scale (QUALIDEM; [19]) is restricted by its
requirement for subjective information from patients and by
the omitting of items for severe dementia.
The QUALID was designed to help assess the outcome
of clinical management and treatment on quality of life in
persons with late-stage dementia residing in long-term care
facilities [14]. The QUALID employs a questionnaire administered by a trained technician or research nurse (recorder) to
professional caregivers (physicians or nurses) who must have
had at least 30 hours of exposure to the resident during the
previous week. The recorder conducts a structured interview
with the professional caregivers (nurses, aides) who infer
patients’ state of mind and level of physical or emotional
comfort or discomfort. The QUALID has a one-week window
of observation. The items, which are all based on observable
behaviors, rated on a 5-point scale, are presented in Table 7.
The QUALID scale has good internal consistency testretest reliability and interrater reliability (ICC = 0.8). The
QUALID scale is sensitive to effects of medications and its
use found that subjects who were receiving neuroleptic or
antidepressant medications were found to have significantly lower (better) QUALID scores. The QUALID has been
translated from English to Finnish, Spanish, Swedish,
German, Dutch, Estonian, and Italian but has been
published only in English, Spanish [20], Dutch [21],
and Swedish [22]. An English form is available free online
at http://www.dementia-assessment.com.au/quality/QUALID Instructions scale.pdf but does not include instructions.
It is also available (with instructions) for subscribers to
the American Psychological Association’s psycTESTS
at http://www.apa.org/pubs/databases/psyctests/index.aspx.
Finally, the QUALID is available (with instructions and at no
charge) from myronweiner@yahoo.com.

2. Evaluation of Global Goals of Palliative Care

2.2. Comfort. Comfort can be defined in three ways: (1) relief
from discomfort, the experience of a person who has had
specific needs met, (2) ease, a state of calm or contentment,
and (3) transcendence, being strengthened or invigorated—
the state in which persons rise above their problems or
challenges [23]. These three ways occur in four contexts: (1)
physical, bodily sensations, (2) social, interpersonal, family,
and societal relationships, (3) psychospiritual, internal awareness of self, including self-esteem, self-concept, sexuality, and
meaning in one’s life and also one’s relationship to a higher
order or being, and (4) environmental, external background
of human experience, that include light, noise, ambience,
color, temperature, and natural versus synthetic elements. In

Global goals of palliative care include maintenance or
improvement of quality of life. Quality of life is a very subjective concept because individuals may have different concepts
of what is important for their quality of life. It is usually
measured by directly asking the person but that is not possible
in persons with advanced dementia. Therefore, measuring
quality of life in these individuals is limited by observing them
and interpreting their behavior, emotions and nonverbal
communications. Important components of quality of life
of persons with dementia are avoidance of discomfort and
opportunity to engage in meaningful activities.
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advanced dementia and at the end of life, comfort is best
determined by absence of discomfort.
Discomfort Scale for Dementia of the Alzheimer Type
(DS-DAT) [24] was developed on the basis of interviews with
experienced nurses who cared for persons with dementia.
Discomfort was defined as a negative emotional and/or physical state in response to internal or environmental conditions.
The DS-DAT has nine items that are made operational by
40 defining characteristics (Table 2). Items are scored 0, 1,
2, or 3 depending on the number of defining characteristics
present and their intensity and duration during a 5-minute
observation period. When items cannot be observed; for
example, a patient with shut eyes could not be rated for a sad
facial expression, the item is scored as NA (not applicable)
and recoded to “0.” The two positively worded items are
reverse coded. Then item’s scores are summed to provide
a total score. High scores mean high levels of observed
discomfort. The research observer must know all the defining
characteristics of each item.
A review of DS-DAT [25] found that several studies
have demonstrated acceptable reliability and validity of the
scale including retrospective assessments. The DS-DAT can
be regarded a classical instrument, based on which several
other instruments for more narrow concepts such as pain
and resistiveness to care have been developed. The scale has
been used in research, the original version as well as several
modifications.
DS-DAT has very good psychometric properties with
excellent internal consistency and factor analyses indicating
that it measures a single concept. Furthermore, discomfort
is moderately associated with acute illness. DS-DAT has also
good interobserver and intraobserver reliability [26]. It has
been used in several research projects in the United States,
Italy, and the Netherlands. While PAINAD can be used easily
in daily clinical practice, DS-DAT is mainly used for research
because it requires extensive training of the observers and the
period of observation is longer.
2.3. Engagement. Persons with dementia develop inability
to independently engage in meaningful activities because of
a deficit of executive function and cognitive impairment.
Therefore, to maintain their quality of life and prevent development of behavioral symptoms of dementia (e.g., agitation
and pacing), they have to be provided with an opportunity
to engage in meaningful activities. These activities have to
be adjusted according to previous interests of a person with
dementia and severity of dementia. Activities are designed to
capture the attention and to promote positive interactions of
persons with dementia with the environment.
The Menorah Park Engagement Scale (MPES) was developed in conjunction with the development of MontessoriBased Dementia Programming—MBDP [27, 28] (Table 6).
Montessori education is an educational approach originally
developed for children by Italian physician and educator
Maria Montessori. It is characterized by an emphasis on
independence, freedom within limits, and respect for a child’s
natural psychological, physical, and social development. In
the Montessori method, task breakdown, guided repetition, progressions from simple to complex and concrete to
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abstract, and the like are inherent in educational activities
for children. Montessori-based programming adapted for
persons with dementia takes advantage of principles used in
dementia interventions, including extensive use of external
cues and reliance on procedural or implicit memory rather
than declarative or explicit memory. Implicit memory is
both unconscious and unintentional and includes procedural
memories, such as how to perform a specific task like swinging a baseball bat or making toast. While implicit memories
are not consciously recalled, they still have an influence on
behavior as well as knowledge of different tasks. Therefore,
people with advanced dementia may still remember how
to do activities that include for instance sorting of pictures
according to labeled categories or names, sorting of buttons
or poker chips, or how to open mouth when approached
with a spoon and may be even able to learn these activities
[29].
MPES is available in two versions; the general MPES form
designed to be used in research projects and the brief MPES
form designed to be used by staff members of programs or
residences serving persons with dementia to enable them
to easily document effects of activities provided to persons
with dementia. The general MPES should be used in research
projects targeted to explore nonpharmacological interventions for problematic or undesirable responsive behaviors, as
well as to document proximal and distal effects of producing
positive engagement. MPES is sensitive to measure effects of
quality activity programming and captures the presence of
altruism in persons with dementia during activities (helping
others), as well as documenting the presence or absence of
problematic behaviors during activities.
The observational measurement of engagement assessment (OME) was developed by Cohen-Mansfield and her
colleagues [30]. OME data are gathered through direct observation and entered onto a handheld computer with special
software developed for this purpose. Outcome variables
on the OME are duration-time in which the participant
is engaged with the stimulus, attention to the stimulus,
and attitude to the stimulus. MPES has some advantages
over OME because it does not require either hardware or
specialized software to obtain data and focuses on different
forms or aspects of engagement and thus can track transitions
in engagement, such as observing a person go from being
asleep to being awake—but not focused on a target activity,
or to watching a target activity, or to actively taking part in a
target activity. However, both of these scales require further
validation.

3. Evaluation of Symptom Control
3.1. Pain. A significant number of patients with advanced
dementia and at the end of life have pain [11]. Comfort is
often diminished or changed into discomfort if the individual
perceives pain. Although pain is not the main symptom of
dementia, persons with dementia often have pain because
of chronic conditions, for example, arthritis, or intercurrent
diseases, for example, urinary tract infection [31]. Very
few if any patients with advanced dementia progress into
a persistent vegetative stage [32] and, therefore, they can
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Table 1: Pain assessment in advanced dementia (PAINAD).

Items
Breathing independent of vocalization
Negative vocalization
Facial expression
Body language
Consolability
For scoring see Warden et al., 2003 [44].

still perceive pain. Pain perception is not diminished in
Alzheimer’s disease but may be actually increased because
patients perceive their pain for a longer time [33]. While
neither stimulus detection nor pain threshold is correlated
to cognitive status in Alzheimer’s disease, the vegetative
response is lower in more advanced disease [34] but facial
responses to noxious stimulation are increased when compared to cognitively intact individuals [35]. However, pain
perception may vary according to the type of dementia.
Persons with frontotemporal dementia may have an increased
pain threshold and pain tolerance [36].
Detection and diagnosis of pain in residents with
advanced dementia is one of the most important factors in
their total care. Nurses may feel highly uncertain about pain
in residents with dementia who could not report if they were
in pain [37]. Patients with advanced dementia are less likely
to have the ability to respond to pain scales, necessitating
the use of observational scales in up to about half of patients
(31%; [38]; 53%; [39]). More than half of residents who were
dying with advanced dementia experienced pain in the last
week of life that was not satisfactorily managed [40, 41]. The
prevalence of pain increases to 80% if rare pain is included
[11].
Several observational scales for measuring pain in noncommunicative patients were developed and recently compared by The City of Hope Pain and Palliative Care Resource
Center (http://prc.coh.org/PAIN-NOA.htm) and by Herr et
al. [42, 43]. The comparison criteria included conceptualization, subjects and setting of the validation papers, ease
of administration and scoring, feasibility, reliability, and
validity. The scale with the highest overall score was Pain
Assessment in Advanced Dementia (PAINAD) [44] (Table 1).
PAINAD has good internal consistency and very good interrater reliability. It has very good concurrent validity when
compared with other pain scales. It has also very good
discriminant validity because it is able to distinguish effect
of analgesics and difference between various severities of
pain. PAINAD was translated into 10 languages and is widely
used for both clinical and research purposes. An instructional
online video is available that shows nurses using PAINAD
at http://links.lww.com/A251. Another good scale according
to the same sources is PACSLAC, (http://prc.coh.org/PAINNOA.htm) and by Herr et al. [42, 43] but it includes 60 items
[45] and some items are not observed in a few minutes, such
as “change in eyes” and “increased confusion” which require
prior familiarity with the patient’s behavior.

Table 2: Discomfort scale-dementia of the Alzheimer type (DSDAT).
Items
Noisy breathing
Negative vocalization
Content facial expression∗
Sad facial expression
Frightened facial expression
Frown facial expression
Relaxed body language∗
Tense body language
Fidgeting body language
∗
reverse coded for calculation of total score.
For scoring see Hurley et al., 1992 [24].

3.2. Behavioral Symptoms of Dementia. Management of
behavioral symptoms in persons with dementia is as important as management of pain in patients with cancer. Behavioral symptoms may appear even before diagnosis of dementia and increase with dementia progression. Initially, there
may be differences in behavioral symptoms in different
types of dementia but in advanced stages all persons with
progressive dementias exhibit similar symptoms. Although
persons with dementia may show several types of behavioral
symptoms and one scale using caregiver reports includes 29
items [46], there are three main behavioral syndromes that
are disturbing for the persons with dementia and/or their
caregivers: agitation, apathy, and rejection of care.
Unfortunately, there is a confusion regarding terminology of behavioral symptoms of dementia. An example is
mislabeled area “agitation/aggression” of the Neuropsychiatric Inventory that is being considered as a gold standard
for evaluation of behaviors in persons with dementia. The
probing questions for “agitation/aggression” are “does the
resident have periods when he/she refuses to let people
help him/her? Is he/she hard to handle? Is he/she noisy
or uncooperative? Does the resident attempt to hurt or hit
others?” These questions clearly ask if the resident rejects care
while interacting with a caregiver. Agitation defined below is
probably captured by the NPI area “aberrant motor behavior”
although this area does not include disruptive vocalization
[47].
Another problem is with the term aggression. What is
aggression? According to the Merriam Webster Dictionary
aggression is “a forceful action or procedure as an unprovoked
attack.” Wikipedia states that “aggression is an intention to
cause harm or an act intended to increase relative social
dominance.” There is no reason to believe that persons with
dementia intend to cause harm or increase social dominance.
Actually, the behavior that some people call “aggression”
is almost always a result of rejection of care that escalates
into combative behavior [7]. Labeling persons with dementia
“aggressive” is blaming the victim, because persons with
dementia most often reject care when they cannot understand
why a caregiver is approaching them. They may consider the
caregiver to be an aggressor and defend themselves against
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Table 3: Scale for Observation of Agitation in Persons with DAT
[dementia of the Alzheimer type] (SOAPD).
Total body movements
Up and down movements
Repetitive movements in place
Mild
Moderate
Extreme
Outward motions
Mild
Moderate
Extreme
High pitched or loud words
Repetitive vocalization
Negative words
For scoring see Hurley et al., 1999 [49].

this unwanted intrusion. It would improve clinical usefulness
of research studies if they used the same terminology as
the clinicians who are evaluating persons with dementia.
Therefore, we would like to propose that the term “aggression”
should be reserved to the few persons with dementia who
actually may strike out without any provocation.
3.2.1. Agitation. Some clinicians and researchers may mislabel all behavioral symptoms of dementia as “agitation.” Use
of this terminology does not take into consideration the circumstances in which behaviors occurred and makes it more
difficult to develop strategies for dealing with these behaviors.
We believe that the term “agitation” should be reserved for
behaviors that occur when the person with dementia is
solitary and is not elicited by an outside stimulus, for example, periods of restlessness, repetitive physical movements,
wandering, and socially inappropriate/disruptive behavior
[48]. Agitation in this narrower sense can be defined as
those behaviors that communicate to others [who observe the
patient] that the person with dementia. . . is experiencing an
unpleasant state of excitement and are [sic] observable without
subjective interpretation, are not behaviors that are invoked
by caregiving activities, are unrelated to known physical needs
of the patient that can be remedied, and are without known
motivational intent [49].
Based on this concept, the Scale for Observation of
Agitation in Persons with DAT [dementia of the Alzheimer
type] (SOAPD) was developed [49]. SOAPD consists of 7
items (Table 3). Three different levels of intensity are built into
the definition of 2 items, so the scoring option is presence
or absence, and if present, then the item was scored for
intensity and duration. The remaining 5 items (if present)
are scored only for duration. Scores for individual items are
weighted by numbers developed by the Magnitude estimate
scaling (MES). MES is the process of assigning numbers
proportionally to stimuli that reflect the intensity of response
[50]. The MES process of weighting resulted in scores that
ranged from 36.5 for mild outward motions with a short
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duration to 787.3 for high/loud vocalization with a long
duration. The theoretic range of the SOAPD is 0–4,445.3.
The SOAPD has been well defined conceptually and
operationally, has excellent psychometric properties, and is
easy to use. SOAPD was used only in one study [51] but
the definition of agitation used in the SOAPD was cited in
a concept clarification article as marking the transition from
the observer’s perspective to the patient’s perspective in the
interpretation of agitation [52].
Other scales that are sometimes used for measurement
of agitation include the Neuropsychiatric Inventory (NPI)
[53] and the Behavioral Pathology in Alzheimer’s Disease
Rating Scale (BEHAVE-AD) [54]. Although they were recommended for the assessment of behavioral disturbances
associated with dementia [55], these scales do not use the
concept of agitation described above. One of the areas of the
NPI scale is labeled “agitation/aggression” but the probing
questions are “does the patient have periods when he/she
refuses to cooperate or won’t let people help him/her? Is
he/she hard to handle?” Therefore, this area really measures
rejection of care and not agitation [47]. Similarly, BEHAVEAD is confusing agitation and rejection of care because one
of the defining characteristics of agitation is “refusal to bathe,
dress, or take medication”.
3.2.2. Apathy. Apathy can be described as a lack of interest
or emotion [56]. It may be the first symptom of cognitive
impairment, especially in the frontotemporal dementia. Apathy has been recognized recently as a common psychiatric
syndrome in the elderly with prevalence ranging from 32 to
93% [56]. Prevalence of apathy increases with the severity
of dementia. Apathy is different from depression although
apathy and depressive symptoms may occur simultaneously.
Analysis of Minimum Data Set (MDS) of 1669 Dutch nursing
home residents showed that apathy and symptoms of depression coexisted in 26.9% of the residents [57]. Apathy and
depressive symptoms responded differently to a multidisciplinary treatment program that included activating strategies,
psychotherapy, and medication [58]. While apathy responded
to activating strategies, symptoms of depression responded
mainly to psychotherapy. The difference between apathy and
depression is also supported by worsening of apathy caused
by antidepressant treatment [59, 60].
Apathy is one of the behavioral areas than can be
measured by the NPI [53]. Another scale commonly used
for measuring apathy is Apathy Evaluation Scale (AES) [61].
This scale had originally 18 items and was more recently
abbreviated to 10-item AES [62] (Table 4). AES-10 correlated
highly with the original scale and its internal consistency
was even higher than consistency of the original scale.
Correlations with indicators of convergent (NPI Apathy)
and discriminant validity (NPI Depression) remained nearly
unchanged in the reduced 10-item scale when compared to
the original version. Correlations with cognitive aspects and
global severity of dementia were reduced in the AES-10 when
compared to the original scale indicating that AES-10 is a
more refined scale that was less confounded by cognitive
aspects of dementia [62]. Presence of apathy may also be
obtained from the MDS that contains two items: withdrawal
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Table 4: Abbreviated Apathy Evaluation Scale (AES-10).

S/he is interested in things
S/he gets things done during the day
Getting things started on his/her own is important to her/him
S/he is interested in having new experiences
S/he puts little effort into anything
S/he approaches life with intensity
Seeing a job through to the end is important to her/him
He/she spends time doing things that interest her/him
S/he has initiative
S/he has motivation

Table 5: Resistiveness to care-dementia of the Alzheimer type
(RTC-DAT) scale.
Items
Turn away
Pull away
Push away
Push/pull
Grab object
Grab person
Adduct

Hit/kick
Say no
Cry
Threaten
Scream/yell
Clench mouth

For scoring Mahoney et al., 1999 [63].

For scoring see Lueken et al., 2007 [62].

Table 6: Items of the Menorah Park Engagement Scale (MPES),
general form.

from activities of interest and reduced social interaction
[48].
3.2.3. Rejection of Care. Terminology of behavioral symptoms of dementia is developing and changing with our
emphasis on patient-centered care. This is documented by
changes from MDS 2.0 to MDS 3.0 where “resist care” is
changed to “reject care that is necessary to achieve the
resident’s goals for health and wellbeing.” Similarly, “abusive
behavior” was changed to “behavioral symptoms directed
toward others” to avoid pejorative labeling of the resident.
Rejection of care is caused by two main factors: lack of
understanding by the person with dementia of caregivers’
intents and by depression [7]. Because the person with
dementia does not understand the need for care, he/she does
not cooperate with the caregiver and may actually actively
resist caregiver’s attempts to provide care. If the caregiver
persists in trying to provide care, person with dementia may
become combative and may be called “abusive.” In addition,
depression may cause “abusive behavior” even in absence of
rejection of care.
Rejection of care may be defined as behavior that
“reject(s) evaluation or care (e.g., blood work, taking medications, and activity of daily living [ADL] assistance) that
is necessary to achieve the resident’s goals for health and
wellbeing” [60]. Rejection of care (RC) requires a patient’s
intent to refuse or reject the care, is not RC if patients’ somnolence prevents them from swallowing medications, does
not include aggressive behaviors with the underlying intent
to harm others, and is not a disruptive behavior occurring
outside of evaluation or caregiving activities. Prevalence of
rejection of care increases with severity of dementia because
of increased lack of understanding of caregiver’s intent and
may be present in up to 35% of nursing home residents
[7].
Rejection of care can be evaluated by the NPI item
“agitation/aggression” as explained above. An observational
scale for measuring rejection of care was also developedResistiveness to Care-Dementia of the Alzheimer Type (RTCDAT) [63]. This scale consists of 13 items that are rated
according to their duration and intensity during 5 minutes
when a care is provided (Table 5). RTC-DAT has good
content validity and excellent internal reliability.

Participated in target activity∗
Tried to leave on own
Left activity alone or with staff
Did/commented on the activity (constructive engagement)∗
Listened/watched target activity (passive engagement)∗
Did or attended to things other than target activity
(other/self-engagement)∗
Slept/kept eyes closed/stared into space (nonengagement)∗
Pleasure (smiling, laughing)
Anxiety/sadness
Helped others
Acted inappropriately
∗

Items included in the Brief Form of MPES.

Table 7: Items of quality of life in late stage dementia scale
(QUALID).
Smiles
Appears sad
Cries
Has facial expression of
discomfort
Appears physically
uncomfortable
Verbalizations express
discomfort

Is irritable or aggressive
Enjoys eating
Enjoys touching/being
touched
Enjoys interacting with
others
Appears calm and
comfortable

For further information see Weiner et al., 2000 [14].

3.3. Respiratory Distress. Shortness of breath is quite common at the end of life with dementia and may be one of
the most disturbing symptoms. Since patients with advanced
dementia may not be able to provide self-report about distress
from dyspnea, they are vulnerable to underrecognition and
undertreatment. Although “shortness of breath” is an item
in EOLD-CAD, it may be useful to evaluate this symptom
in more detail. RDOS was developed based on evidence of
activation of fear center (amygdala) by an asphyxia threat
and on presence of specific behaviors activated by pulmonary
stress [64].
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The Respiratory Distress Observation Scale (RDOS) has
good internal consistency and its validity was documented
by significant correlation with dyspnea visual analog scale
and with peripheral oxygen saturation. In patients with
pain, RDOS score correlated with numeric pain report and
this correlation was due to presence of tachycardia. When
heart rate was removed, there was no correlation between
pain and RDOS scores. Discriminant validity of RDOS was
documented by differences of RDOS scores between patients
with dyspnea and pain [64].

4. Evaluation of Outcomes of Palliative Care at
the End of Life
Currently, the care provided for persons with dementia at
the end of life is less than optimal. In the United States,
persons with dementia experience distressing symptoms
(especially dyspnea and pain) during their last 3 months of
life, and almost half of them are exposed to at least one
burdensome intervention (hospitalization, emergency room
visit, parenteral therapy, or tube feeding) [65]. The situation
is not better in Europe where data from Belgium and the
Netherlands indicate that persons with dementia experience
pain, more than one quarter of them have pressure sores,
and almost one quarter are physically restrained [11, 40].
According to the Stewart’s overall conceptual model of factors
affecting quality and length of life of dying patients and
their families’ outcomes of care include quality of life and
satisfaction with care [13].
Three EOLD scales were developed based on responses of
family caregivers of persons with dementia who died within
the last year [66]. All items in the questionnaire asked for
information related to the care recipient’s last 90 days of life
or to the care recipient’s condition during the dying process.
The scales were compared with other scales used with people
with advanced dementia by [67]. We will list two of the three
scales because the third, the EOLD-Symptom Management
scale, did not perform well in this comparison.
4.1. Comfort Assessment in Dying with Dementia (EOLDCAD). Maintenance of comfort during dying may be the
most important factor for quality of lifer. Of the instruments
measuring quality of dying, EOLD-CAD [68] and MiniSuffering State Examination (MSSE) [69] met more criteria
than others, but EOLD-CAD performed better on content
and construct validity than MSSE [6]. Questions in EOLDCAD were constructed using an array of the symptoms and
conditions commonly observed during the dying process in
persons with dementia [70] (Table 8). Factor analysis showed
that the scale is composed of four factors: physical distress,
emotional distress, wellbeing, and dying symptoms.
The EOLD-CAD is valid and satisfied all validity factors (prior relevant use, coherence of construct, convergent
validity to overall rating and other instruments measuring
the same construct, and factorial validity) [71]. Reliability
is excellent for the whole scale and at least acceptable for
individual subscales. Convergent validity of EOLD-CAD was
supported by significant correlation with QUALID. EOLD
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Table 8: Items in scales measuring quality of care at the end of life
with dementia.
Comfort assessment in dying
with dementia (EOLD-CAD)

Respiratory distress
observation scale (RDOS)

Discomfort1
Pain1
Restlessness1
Shortness of breath1,2
Choking2
Gurgling2
Difficulty swallowing2
Fear3
Anxiety3
Crying3
Moaning3
Serenity (inner peace)4
Peace4
Calm4

Heart rate
Respiratory rate
Restlessness
Accessory muscle use
Grunting at end-expiration
Nasal flaring
Fearful facial expression

1

Items in Physical distress subscale, 2 items in dying symptoms subscale,
items in emotional distress subscale, and 4 item in well-being subscale.
For scoring see Volicer et al., 2001 [68] and Campbell, 2008 [64].

3

scales were used in two large projects investigating end of
life in patients with dementia prospectively [65] and several
publications resulted from these studies [66].
4.2. Satisfaction with Care. Satisfaction of family members
with care provided to their relatives could be measured by
End-Of-Life in Dementia-Satisfaction With Care (EOLDSWC) scale. The questions used for development of this
scale were based on the MediCaring questionnaire addressing
satisfaction with care [72]. Fifteen questions used a four point
scale ranging from “strongly agree” (4) to strongly disagree (1)
and included a “not applicable” selection. Negative questions
were reverse-coded so that, for all responses, higher numbers
represented more satisfaction. “Not applicable” responses
were coded as “missing.” Most items included were considered applicable by more than 94% of the respondents with the
exception of one statement. This item also correlated strongly
with another item and, therefore, it was deleted. Factor
analysis showed that the scale consisted of only one factor.
Four other items had high corrected item-total correlations
(𝑟 > 0.8) and were deleted. The possible scores on this
remaining 10-item scale range from 10 to 40 with higher
scores indicating more satisfaction.
EOLD-SWC had the highest rating regarding relevance
and ease of use of the five scales measuring quality of
care. Its validity was supported because it measured single
construct and correlated highly with the Decision Satisfaction
Inventory (DSI) (𝑟 = 0.81) [73], and with global assessment
of care (𝑟 = 0.7). The scale is reliable with Cronbach alpha
ranging from 0.83 to 0.9. It was sensitive to detecting changes
in health care proxies satisfaction with the care of residents
when addressing whether the health care provider spent >25
minutes discussion the resident’s advanced care planning,

8
whether the physician counseled about the resident’s life
expectancy, whether resident resided in a special care unit,
and whether the physician counseled possible resident health
problems. Scores of EOLD-SWC exhibited a normal distribution and provide the opportunity to detect improvement
in care strategies.
Perspectives. Observation of persons with advanced dementia
provides rich information about their condition. Formation
of scales based on these observations is important for research
studying effects of various strategies for dementia care. It will
be important to investigate how these scales could be useful in
daily care. It will be important to document whether numeric
scores improve communication between staff members, and
between staff and families.
Another issue that requires further investigation is specificity of some of these scales. For instance, high PAINAD
score may indicate not only presence of pain but also
discomfort caused by other causes [74]. Different persons
may respond to pain by different changes of behaviors and
expressions which may allow for the assessment of pain or
no pain, but not for pain intensity with these types of scales.
However, use of scales that do not refer to previous conditions
is needed because of the high turnover of caregivers for
persons with dementia, and because some caregivers may not
be familiar with the baseline state of the person and might
have difficulties recognizing changes in their condition.
The measures in this review cover important outcomes of
palliative care in dementia. However, at present scales are not
available for all outcomes. For example, there is no scale for
spiritual wellbeing specific to dementia. However, spiritual
items (e.g., peace, which is also indicative of quality of care
[75]) are included in the EOLD-CAD but developing a comprehensive measure of spiritual wellbeing may be challenging
in advanced dementia. Most measures we discussed have
been developed for, or validated in advanced dementia or
dementia at the end of life specifically. However, some were
not validated in this population, especially those addressing
behavioral symptoms (e.g., apathy), and these scales need
to be included in future research as relevant to advanced
dementia and dementia at the end of life.
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